LILRB2 and colorectal carcinoma: Moreover, LILRB2 expression is markedly upregulated in CRC, where its elevation correlates with unfavorable clinicopathological parameters, including poor-to-moderate differentiation, lymph node metastasis (LNM), advanced TNM stage, and poor prognosis (Wang et al., 2023).